The G protein-first activation mechanism of opioid receptors by Gi protein and agonists | QRB Discovery | Cambridge Core
The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain | Signal Transduction and Targeted Therapy
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances
Singular Interface Dynamics of the SARS-CoV-2 Delta Variant Explained with Contact Perturbation Analysis | Journal of Chemical Information and Modeling
IJMS | Free Full-Text | Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant’s Superior Transmission
Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization | PNAS
Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants | Nature Communications
Molecules | Free Full-Text | Severe Acute Respiratory Syndrome Coronavirus-2 Inactivation Activity of the Polyphenol-Rich Tea Leaf Extract with Concentrated Theaflavins and Other Virucidal Catechins
Kappa Delta Sorority - Gamma Kappa Chapter at UL Lafayette
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion | Nature
Frontiers | Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
Vaccines | Free Full-Text | The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
Novel Mixed NOP/Opioid Receptor Peptide Agonists | Journal of Medicinal Chemistry
Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum | NEJM
Emergence of SARS‐CoV‐2 Omicron variant and strategies for tackling the infection - Wu - 2022 - Immunity, Inflammation and Disease - Wiley Online Library
Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2: Molecular Therapy
Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies | Cell Discovery
Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies | Nature Communications
Frontiers | The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
Frontiers | Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Management
SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern | PNAS
Emerging SARS-CoV-2 variants of concern and potential intervention approaches | Critical Care | Full Text
A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS‐CoV‐2 Variants of Concern - Zhang - 2022 - Chemistry – A European Journal - Wiley Online Library
Pharmaceuticals | Free Full-Text | Opioid Analgesia and Opioid-Induced Adverse Effects: A Review
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination - ScienceDirect
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
IJERPH | Free Full-Text | Shorter Incubation Period among Unvaccinated Delta Variant Coronavirus Disease 2019 Patients in Japan
